Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 18.27 | -42.42 | 34.08 | -59.45 |
Depreciation/ Depletion | 60.72 | 59.12 | 56.97 | 60.25 |
Non- Cash Items | 76.83 | 39.03 | 68.50 | 64.83 |
Changesin Working Capital | 68.87 | 77.93 | -64.54 | -44.26 |
Cashfrom Operating Activities | 224.69 | 133.65 | 95.01 | 21.38 |
Capital Expenditures | -29.42 | -30.06 | -24.97 | -31.24 |
Other Investing Cash Flow Items Total | 12.39 | 81.76 | 41.61 | 2.62 |
Cashfrom Investing Activities | -17.03 | 51.70 | 16.64 | -28.62 |
Financing Cash Flow Items | -87.14 | -79.49 | -78.81 | -112.04 |
Issuance( Retirement)of Debt Net | -118.29 | -106.10 | -39.54 | 124.65 |
Cashfrom Financing Activities | -205.43 | -185.58 | -119.38 | 11.49 |
Net Changein Cash | 2.23 | -0.23 | -7.73 | 4.25 |
Cash Interest Paid | 87.14 | 79.49 | 78.81 | 112.04 |
Cash Taxes Paid | 0.00 | 0.00 | 0.00 | 3.71 |
Total Cash Dividends Paid | - | - | -1.03 | -1.12 |
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Profit Loss Nectar Lifesciences Balance Sheet Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks